18:15 28/03/2017 Looking at the Levels for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Looking at the Levels for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
The Standard - 12 hours ago
Looking at shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), the company has an EV (Enterprise Value) of 431506. Enterprise Value is a measure of the total value of a specific company.

16:33 28/03/2017 Inspecting more closely technicals of Arena Pharmaceuticals, Inc. (ARNA)
Inspecting more closely technicals of Arena Pharmaceuticals, Inc. (ARNA)
USA Commerce Daily - 13 hours ago
With all other things going on, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has been on a run - rising 1.36 percent in just three months.

14:30 28/03/2017 Today's Research Reports on Biotech Stocks to Watch: Arena Pharmaceuticals and ...
Today's Research Reports on Biotech Stocks to Watch: Arena Pharmaceuticals and ...
Yahoo Finance - 15 hours ago
Arena Pharmaceuticals' investors breathe a sigh of relief with the company now experiencing positive results with regard to its share value.

13:56 28/03/2017 Arena Pharmaceuticals, Inc. (ARNA) hit its 52 Week high of $2.16 on Jun 9, 2016
Arena Pharmaceuticals, Inc. (ARNA) hit its 52 Week high of $2.16 on Jun 9, 2016
The Newburgh Press - 16 hours ago
Considering the performance, Arena Pharmaceuticals, Inc. (ARNA)'s shares have the potential to reach a high EPS of -0.02 per share, and a low EPS of -0.1 per share in the current quarter.
Latest Stocks: Arena Pharmaceuticals, Inc. (ARNA) Receives Consensus Rating of ... - Petro Global News 24
Arena Pharmaceuticals, Inc. performed Very Well with a change of 0.69% in the ... - Free Observer

13:22 27/03/2017 Arena Pharmaceuticals to Present at the 16th Annual Needham Healthcare ...
Arena Pharmaceuticals to Present at the 16th Annual Needham Healthcare ...
PR Newswire (press release) - Mar 27, 2017
SAN DIEGO, March 27, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today announced that Amit Munshi, the ...

12:33 20/03/2017 Arena Pharmaceuticals Appoints Dr. Preston Klassen, MD, MHS as Executive Vice ...
Arena Pharmaceuticals Appoints Dr. Preston Klassen, MD, MHS as Executive Vice ...
Yahoo Finance - Mar 20, 2017
SAN DIEGO, March 20, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today announced the appointment of Dr.

23:03 14/03/2017 Company Update (NASDAQ:ARNA): Arena Pharmaceuticals, Inc. Announces 4Q and ...
Company Update (NASDAQ:ARNA): Arena Pharmaceuticals, Inc. Announces 4Q and ...
Smarter Analyst - Mar 14, 2017
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported financial results for the fourth quarter and full-year ended December 31, 2016 and provided a corporate update.
Arena Pharmaceuticals (ARNA) Posts Q4 Earnings, Revenues Up - Yahoo Finance
Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and ... - PR Newswire (press release)

21:38 08/03/2017 Arena Pharmaceuticals to Present at the 27th Annual Oppenheimer Healthcare ...
Arena Pharmaceuticals to Present at the 27th Annual Oppenheimer Healthcare ...
Yahoo Finance - Mar 8, 2017
SAN DIEGO, March 8, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today announced that Amit Munshi, the Company's ...

21:22 06/03/2017 Arena Pharmaceuticals to Provide Corporate Update and Release Fourth Quarter ...
Arena Pharmaceuticals to Provide Corporate Update and Release Fourth Quarter ...
GlobeNewswire (press release) - Mar 6, 2017
SAN DIEGO, March 06, 2017 (GLOBE NEWSWIRE) -- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), today announced that the Company will provide a corporate update and release its fourth quarter and full-year 2016 financial results on Tuesday, March 14, ...
Today Arena Pharmaceuticals, Inc. (ARNA) Receives Consensus Rating of “Hold ... - DailyQuint
Analyst Earnings Report: Arena Pharmaceuticals (NASDAQ:ARNA) - News Oracle

12:22 27/02/2017 Arena Pharmaceuticals (ARNA) Q4 Earnings: What to Expect?
Arena Pharmaceuticals (ARNA) Q4 Earnings: What to Expect?
Yahoo Finance - Feb 27, 2017
Arena Pharmaceuticals, Inc. ARNA is expected to report fourth-quarter 2016 results next month. The company delivered a positive earnings surprise of 28.57% last quarter.
What's On Focus As Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Reports Q4? - StockNewsUnion
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has 1 year Price Target of $4.5 - The Newburgh Press